LTFS
SRPT icon

Ladenburg Thalmann Financial Services’s Sarepta Therapeutics SRPT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$516K Buy
6,448
+2,551
+65% +$257K ﹤0.01% 1790
2019
Q3 		$294K Buy
3,897
+1,678
+76% +$198K ﹤0.01% 2186
2019
Q2 		$338K Buy
2,219
+40
+2% +$4.86K ﹤0.01% 2051
2019
Q1 		$260K Buy
2,179
+822
+61% +$106K ﹤0.01% 2199
2018
Q4 		$147K Sell
1,357
-476
-26% -$59.5K ﹤0.01% 2469
2018
Q3 		$295K Buy
1,833
+585
+47% +$80K ﹤0.01% 2007
2018
Q2 		$93K Hold
1,248
– – ﹤0.01% 2795
2018
Q1 		$93K Sell
1,248
-1,534
-55% -$102K ﹤0.01% 2795
2017
Q4 		$155K Sell
2,782
-1,480
-35% -$78.4K ﹤0.01% 2407
2017
Q3 		$193K Buy
4,262
+2,493
+141% +$99.6K ﹤0.01% 2141
2017
Q2 		$59K Buy
1,769
+67
+4% +$2.18K ﹤0.01% 2915
2017
Q1 		$50K Buy
1,702
+498
+41% +$15.4K ﹤0.01% 2916
2016
Q4 		$33K Sell
1,204
-3,200
-73% -$129K ﹤0.01% 3149
2016
Q3 		$271K Sell
4,404
-488
-10% -$14.8K ﹤0.01% 1548
2016
Q2 		$93K Buy
4,892
+3,000
+159% +$55.6K ﹤0.01% 2208
2016
Q1 		$37K Sell
1,892
-13
-0.7% -$227 ﹤0.01% 2825
2015
Q4 		$73K Hold
1,905
– – ﹤0.01% 2298
2015
Q3 		$62K Buy
1,905
+628
+49% +$21.3K ﹤0.01% 2329
2015
Q2 		$39K Hold
1,277
– – ﹤0.01% 2765
2015
Q1 		$17K Buy
1,277
+1,000
+361% +$13.3K ﹤0.01% 3294
2014
Q4 		$4K Buy
+277
New +$4.69K ﹤0.01% 3835
2014
Q1 		– Sell
-300
Closed -$6K – 3841
2013
Q4 		$6K Buy
+300
New +$8.91K ﹤0.01% 3180

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SRPT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Sarepta Therapeutics (SRPT) stake by 65% in Q4 2019, buying an estimated $257K and bringing the position to 6,448 shares worth $516K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Ladenburg Thalmann Financial Services first reported a position in SRPT in Q4 2013 and has held it in 22 quarters since. 389 funds tracked by Wall St. Rank hold SRPT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 6,448 shares of Sarepta Therapeutics worth $516K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 2,551 Sarepta Therapeutics shares in Q4 2019, an estimated $257K.
  • Sarepta Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1790 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Sarepta Therapeutics in Q4 2013 and has held it in 22 quarters since.
  • 389 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.